Dr. Umar A. Shuaib, MD
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Years since graduation
- 13
- In the NPI registry since
- 2014
- Medicare patients seen, 2024
- 313
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2014Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
OH license 62560 - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Cleveland Clinic Cleveland, OH
- Hillcrest Hospital Mayfield Heights, OH
- Akron General Medical Center Akron, OH
- Fairview Hospital Cleveland, OH
- Mercy Medical Center Canton, OH
Medical groups
- Cleveland Clinic (7,090 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 313
- Services billed
- 913
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 147 | 103 |
| Established patient office or other outpatient visit, 20-29 minutes | 95 | 75 |
| Established patient office or other outpatient visit, 40-54 minutes | 56 | 54 |
| New patient office or other outpatient visit, 60-74 minutes | 47 | 47 |
| New patient office or other outpatient visit, 45-59 minutes | 46 | 46 |
| Established patient office or other outpatient visit, 10-19 minutes | 25 | 21 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Carbidopa-Levodopa (carbidopa/levodopa) Other prescribers in Cleveland, OH | 607 |
| Gabapentin Other prescribers in Cleveland, OH | 119 |
| Primidone Other prescribers in Cleveland, OH | 118 |
| Donepezil Hcl Other prescribers in Cleveland, OH | 62 |
| Ropinirole Hcl Other prescribers in Cleveland, OH | 60 |
| Mirtazapine Other prescribers in Cleveland, OH | 59 |
| Clonazepam Other prescribers in Cleveland, OH | 58 |
| Amantadine (amantadine hcl) Other prescribers in Cleveland, OH | 57 |
| Carbidopa-Levodopa Er (carbidopa/levodopa) Other prescribers in Cleveland, OH | 56 |
| Carbidopa | 47 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 3 payments worth $221 in total to this clinician.
| Insightec,inc | $198 |
|---|---|
| AbbVie Inc. | $23.64 |
| Food and Beverage | $221 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $92,031 in research payments for these studies, mostly to the institutions running them.
- A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of UCB0022 in Study Participants With Advanced Parkinson's Disease
UCB SA · Completed · NCT06055985
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.